Abstract:The pool of microbes inhabiting our body is known as "microbiota" and their collective genomes as "microbiome". The colon is the most densely populated organ in the human body, although other parts, such as the skin, vaginal mucosa, or respiratory tract, also harbour specific microbiota. This microbial community regulates some important metabolic and physiological functions of the host, and drives the maturation of the immune system in early life, contributing to its homeostasis during life. Alterations of the intestinal microbiota can occur by changes in composition (dysbiosis), function, or microbiota-host interactions and they can be directly correlated with several diseases. The only disease in which a clear causal role of a dysbiotic microbiota has been demonstrated is the case of Clostridium difficile infections. Nonetheless, alterations in composition and function of the microbiota have been associated with several gastrointestinal diseases (inflammatory bowel disease, colorectal cancer, or irritable bowel syndrome), as well as extra-intestinal pathologies, such as those affecting the liver, or the respiratory tract (e.g., allergy, bronchial asthma, and cystic fibrosis), among others. Species of Bifidobacterium genus are the normal inhabitants of a healthy human gut and alterations in number and composition of their populations is one of the most frequent features present in these diseases. The use of probiotics, including bifidobacteria strains, in preventive medicine to maintain a healthy intestinal function is well documented. Probiotics are also proposed as therapeutic agents for gastrointestinal disorders and other pathologies. The World Gastroenterology Organization recently published potential clinical applications for several probiotic formulations, in which species of lactobacilli are predominant. This review is focused on probiotic preparations containing Bifidobacterium strains, alone or in combination with other bacteria, which have been tested in human clinical studies. In spite of extensive literature on and research into this topic, the degree of scientific evidence of the effectiveness of probiotics is still insufficient in most cases. More effort need to be made to design and conduct accurate human studies demonstrating the efficacy of probiotics in the prevention, alleviation, or treatment of different pathologies.

Bacteria require phase separation for fitness in the mammalian gut

Analysis of a phase-variable restriction modification system of the human gut symbiont Bacteroides fragilis

Bacteroides thetaiotaomicron in the gut: Molecular aspects of their interaction

Spatially distinct physiology of Bacteroides fragilis within the proximal colon of gnotobiotic mice

Microbial interactions and the homeostasis of the gut microbiome: the role of Bifidobacterium

Physiological Role of Gut Microbiota for Maintaining Human Health

A mutant fitness compendium in Bifidobacteria reveals molecular determinants of colonization and host-microbe interactions

A mucin-responsive hybrid two-component system controls Bacteroides thetaiotaomicron colonization and gut homeostasis

The human gut microbiome in health and disease: time for a new chapter?

The Role of Microbiota on the Gut Immunology

Functional genetics of human gut commensal Bacteroides thetaiotaomicron reveals metabolic requirements for growth across environments

Phase separating Rho: a widespread regulatory function of disordered regions in proteins revealed in bacteria

Streamlined Genetic Manipulation of Diverse Bacteroides and Parabacteroides Isolates from the Human Gut Microbiota

Establishment of the improved colonization of Escherichia coli laboratory strain in the intestine mediated by single gene deletion

Exploring Bacteroidetes: Metabolic key points and immunological tricks of our gut commensals

The Human Gut Microbiome - A Potential Controller of Wellness and Disease

Good or bad: gut bacteria in human health and diseases

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Gut Microbiota Defines Functional Direction of Colonic Regulatory T Cells with Unique TCR Repertoires

Phase-variable restriction/modification systems are required for Helicobacter pylori colonization

Modulation of Gut Microbiota in Pathological States